Abstract:Gene transfer to cardiomyocytes in vivo has been received more research attentions in the last decade but remains a key hurdle. In the present study, we attempted to explore the feasibility of gene transfer to cardiomyocytes in vivo mediated by ultrasound targeted microbubble destruction (UTMD) accompanied by PEI. This is a comparative study of transgene expression after systemic delivery. The solution containing phosphate-buffered saline (PBS), plasmid, complexes of plasmid or PEI/plasmid and liposome microbubbles was injected by tail vein. The hearts of anesthetized mice was exposed to ultrasound irradiation. The efficiencies of luciferase transgene expression were determined. Tissue specimens were viewed to determine the presence of fluorescin expression. The application of UTMD significantly increased the luciferase activity (67-fold) in vivo compared to plasmid and microbubble alone. More importantly, the increase in transgene expression was related to UTMD with the presence of PEI dramatically. Regardless of ultrasound exposure, expression in other organs was close to background except for the liver and lung. Hematoxylin and eosin staining showed similar results between control and transfected groups. An atraumatic and targeted gene delivery technique based on UTMD and PEI has been developed to transfect heart tissue. We concluded that, if suitable target gene was added, the novel technique was highly effective in many kinds of heart diseases.

Ultrasound and Liposome Microbubble-Mediated Targeted Gene Transfer to Cardiomyocytes in Vivo Accompanied by Polyethylenimine